The India preclinical Contract Research Organization (CRO) market was valued at USD 183.3 million in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 11.4% from 2024 to 2030. This growth is primarily driven by the increasing global trend of outsourcing R&D for clinical trials, rapid technological advancements, and India’s unique advantages—such...